Results 91 to 100 of about 226,036 (351)
The optimal treatment of multivessel coronary artery disease [PDF]
, 2014 The practice of percutaneous coronary intervention has overtaken coronary bypass surgery in the treatment of ischaemic heart disease. Several randomized controlled as well as registry and observational trials have addressed the issue of patient selection
Manche, Alexander
core
New England Journal of Medicine, 1993 BACKGROUND Despite the widespread use of intravenous thrombolytic therapy and of immediate percutaneous transluminal coronary angioplasty for the treatment of acute myocardial infarction, randomized comparisons of the two approaches to reperfusion are ...
F. Zijlstra +5 more
semanticscholar +1 more source
Journal of the American College of Cardiology, 1984 The potential of repeat percutaneous transluminal coronary angioplasty as a mode of therapy for recurrence of stenosis after initially successful angioplasty was examined on the basis of data on all 514 patients with successful angioplasty at Emory University before April 1982. Recurrence was found in 171 (33%) of the 514 patients.
John S. Douglas +7 more
openaire +2 more sources
Complementary Medicine Journal of Faculty of Nursing and Midwifery, 2022 Objective: Postoperative anxiety, such as coronary artery bypass graft surgery, is one of the most common stressors in this group of patients, which can endanger their physical and mental health.
Maryam Asadi Mobarakeh, Marzieh Ziaeirad
doaj
Effects of balloon injury on neointimal hyperplasia in steptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. [PDF]
, 2001 BACKGROUND: The mechanisms of increased neointimal hyperplasia after coronary interventions in diabetic patients are still unknown. METHODS AND RESULTS: Glucose and insulin effects on in vitro vascular smooth muscle cell (VSMC) proliferation and ...
Carriero M.V. +13 more
core
Dislocation of a cerebral protection device component during carotid stenting: A case report of favorable outcome from conservative management after failure of retrieval [PDF]
, 2018 tINTRODUCTION: Cerebral-protection devices (CPDs) are a well-established system for reduction ofembolic risk in carotid artery angioplasty and stenting (CAS).
Avruscio, Giampiero +3 more
core +2 more sources
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
Postepy w kardiologii interwencyjnej = Advances in interventional cardiology, 2015 Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but potentially life-threatening disease of the pulmonary circulation [1]. The pathogenesis of CTEPH is not entirely clear.
M. Kurzyna +4 more
semanticscholar +1 more source
ChemMedChem, EarlyView.PEGylation of the WRAP5‐based nanoparticles via acyl hydrazone linkers is achieved to obtain a pH‐sensitive small interfering ribonucleic acid‐targeted delivery. In acidic extracellular conditions (pH 5) occurring during myocardial ischemia‐reperfusion injury, this optimized delivery system is the only one showing efficient silence of the Fas ...
Giulia Di Gregorio +14 more
wiley +1 more source
Bindarit inhibits human coronary artery smooth muscle cell proliferation, migration and phenotypic switching [PDF]
, 2012 Bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs) synthesis, reduces neointimal formation in animal models of vascular injury and recently has been shown to inhibit in-stent late loss in a placebo-controlled phase II clinical trial.
Angelo Guglielmotti +12 more
core +6 more sources